Effects of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAP

Sleep Medicine

Volumn 4, Issue 5, 2003, Pages 393-402

  Dinges, David F ^a   Weaver, Terri E ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Functional status; Modafinil; nCPAP; Obstructive sleep apnea; PVT performance; Quality of life; Sustained attention

Indexed keywords

MODAFINIL; PLACEBO;

ADULT; AGED; ALERTNESS; ARTICLE; ATTENTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; FREQUENCY ANALYSIS; FUNCTIONAL ASSESSMENT; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NERVOUSNESS; OUTCOMES RESEARCH; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SCORING SYSTEM; SLEEP APNEA SYNDROME; SOMNOLENCE; STATISTICAL ANALYSIS; TASK PERFORMANCE; THORAX PAIN;

EID: 0141557909     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1389-9457(03)00108-4     Document Type: Article

References (97)

1. Naegele B, Thouvard V, Pepin JL, et al. Deficits of cognitive executive functions in patients with sleep apnea syndrome. Sleep 1995;18:43-52.
2. Bedard MA, Montplaisir J, Richer F, et al. Obstructive sleep apnea syndrome: pathogenesis of neuropsychological deficits. J Clin Exp Neuropsychol 1991;13:950-9.
3. Feuerstein C, Naegele B, Pepin JL, et al. Frontal lobe-related cognitive functions in patients with sleep apnea syndrome before and after treatment. Acta Neurol Belg 1997;97:96-107.
4. Greenberg GD, Watson RK, Deptula D. Neuropsychological dysfunction in sleep apnea. Sleep 1987;10:254-62.
5. Berry DT, Webb WB, Block AJ, et al. Nocturnal hypoxia and neuropsychological variables. J Clin Exp Neuropsychol 1986;8: 229-38.
6. Findley LJ, Barth JT, Powers DC, et al. Cognitive impairment in patients with obstructive sleep apnea and associated hypoxemia. Chest 1986;90:686-90.
7. Telakivi T, Kajaste S, Partinen M, et al. Cognitive function in middle-aged snorers and controls: role of excessive daytime somnolence and sleep-related hypoxic events. Sleep 1988;11:454-62.
8. Montplaisir J, Bedard MA, Richer F, et al. Neurobehavioral manifestations in obstructive sleep apnea syndrome before and after treatment with continuous positive airway pressure. Sleep 1992;15: S17-S19.
9. Kim HC, Young T, Matthews CG, et al. Sleep-disordered breathing and neuropsychological deficits. A population-based study. Am J Respir Crit Care Med 1997;156:1813-9.
10. Munoz A, Mayoralas LR, Barbe F, et al. Long-term effects of CPAP on daytime functioning in patients with sleep apnoea syndrome. Eur Respir J 2000;15:676-81.
11. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. J Am Med Assoc 2000;283:1829-36.
12. Peppard P, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84.
13. Ulfberg J, Carter N, Edling C. Sleep-disordered breathing and occupational accidents. Scand J Work Environ Health 2000;26: 237-42.
14. Findley LJ, Unverzagt ME, Surratt PM. Automobile accidents involving patients with obstructive sleep apnea. Am J Respir Dis 1988;138:337-40.
15. Findley L, Unverzagt M, Guchu R, et al. Vigilance and automobile accidents in patients with sleep apnea or narcolepsy. Chest 1995;108: 619-24.
16. Aldrich MS. Automobile accidents in patients with sleep disorders. Sleep 1989;12:487-94.
17. Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. N Engl J Med 1999;340:847-51.
18. Barbe F, Pericas J, Munoz A, et al. Automobile accidents in patients with sleep apnea: an epidemiological and mechanistic study. Am J Respir Crit Care Med 1998;158:18-22
19. Masa JF, Rubio M, Findley LJ. Habitually sleepy drivers have a high frequency of automobile crashes associated with respiratory disorders during sleep. Am J Respir Crit Care Med 2000;162: 1407-12.
20. Young T, Blustein J, Finn L, et al. Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep 1997;20:608-13.
21. George CF, Smiley A. Sleep apnea & automobile crashes. Sleep 1999; 22:790-5.
22. Wu H, Yan-Go F. Self-reported automobile accidents involving patients with obstructive sleep apnea. Neurology 1996;46:1254-7.
23. He J, Kryger M, Zorick F, et al. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 1988; 94:9-14.
24. Peker Y, Hedner J, Kraiczi H, et al. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000;162:81-6.
25. Lavie P, Herer P, Peled R, et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 1995;18:149-57.
26. Lindberg E, Janson C, Svardsudd K, et al. Increased mortality among sleepy snorers: a prospective population based study. Thorax 1998;53: 631-7.
27. Gliklich RE, Taghizadeh F, Winkelman JW. Health status in patients with disturbed sleep and obstructive sleep apnea. Otolaryngol Head Neck Surg 2000;122:542-6.
28. Yang EH, Hla KM, McHorney CA, et al. Sleep apnea and quality of life. Sleep 2000;23:535-41.
29. Flemons WW, Reimer MA. Development of a disease-specific health-related quality of life questionnaire for sleep apnea. Am J Respir Crit Care Med 1998;158:494-503.
30. Gall R, Isaac L, Kryger M. Quality of life in mild obstructive sleep apnea. Sleep 1993;16:S59-S61.
31. D'Ambrosio C, Bowman T, Mobsenin V. Quality of life in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure - a prospective study. Chest 1999;115:123-9.
32. Fornas C, Ballester E, Arteta E, et al. Measurement of general health status in obstructive sleep apnea hypopnea patients. Sleep 1995;18: 876-9.
33. Weaver TE, Laizner AM, Evans LK, et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 1997;20:835-43.
34. Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Med Care 1992;30:473-83.
35. Hunt SM, McEwen J, McKenna SP. Perceived health: age and sex comparisons in a community. J Epidemiol Commun Health 1984;38: 156-60.
36. Finn L, Young T, Palta M, et al. Sleep-disordered breathing and self-reported general health status in the Wisconsin Sleep Cohort Study. Sleep 1998;21:701-6.
37. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. J Am Med Assoc 1989;262:907-13.
38. Loube DI, Gay PC, Strohl KP, et al. Indications for positive airway pressure treatment of adult obstructive sleep apnea patients. A consensus statement. Chest 1999;115:863-6.
39. Strollo Jr PJ, Rogers R. Obstructive sleep apnea. N Engl J Med 1996; 334:99-104.
40. Jenkinson C, Davies R, Mullins R, et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999;353:2100-5.
41. Engleman HM, Martin SE, Deary IJ, et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994;343:572-5.
42. Engleman HM, Martin SE, Kingshott RN, et al. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998;53:341-5.
43. Engleman HM, Kingshott RN, Wraith PK, et al. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159:461-7.
44. Redline S, Adams N, Strauss ME, et al. Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med 1998;157:858-65.
45. Kribbs NB, Pack AI, Kline LR, et al. Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea. Am Rev Respir Dis 1993;147:1162-8.
46. Bedard MA, Montplaisir J, Malo J, et al. Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP). J Clin Exp Neuropsychol 1993;15:330-41.
47. Lamphere J, Roehrs T, Wittig R, et al. Recovery of alertness after CPAP in apnea. Chest 1989;96:1364-7.
48. Sforza E, Krieger J. Daytime sleepiness after long-term continuous positive airway pressure (CPAP) treatment in obstructive sleep apnea syndrome. J Neurol Sci 1992;110:21-6.
49. Meurice JC, Marc I, Series F. Efficacy of auto-CPAP in the treatment of obstructive sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1996;153:794-8.
50. Poceta JS, Timms RM, Jeong DU, et al. Maintenance of wakefulness test in obstructive sleep apnea syndrome. Chest 1992;101:893-7.
51. Bennett LS, Barbour C, Langford B, et al. Health status in obstructive sleep apnea: relationship with sleep fragmentation and daytime sleepiness, and effects of continuous positive airway pressure. Am J Respir Crit Care Med 1999;159:1884-90.
52. Flemons W. Measuring health related quality of life in sleep apnea. Sleep 2000;23:S109-14.
53. George CF, Boudreau AC, Smiley A. Effects of nasal CPAP on simulated driving performance in patients with obstructive sleep apnoea. Thorax 1997;52:648-53.
54. Guilleminault C, Philip P. Tiredness and somnolence despite initial treatment of obstructive sleep apnea syndrome (what to do when an OSAS patient stays hypersomnolent despite treatment). Sleep 1996; 19:S117-22.
55. Littner M, Johnson SF, McCall WV, et al. Practice parameters for the treatment of narcolepsy: an update for 2000. Sleep 2001;24: 451-66.
56. Broughton RJ, Fleming JA, George CF, et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 1997;49: 444-51.
57. Modafinil US. in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 1998;43:88-97.
58. Modafinil US. in Narcolepsy Multicenter Study Group. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology 2000;54:1166-75.
59. Beusterien KM, Rogers AE, Walsleben JA, et al. Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep 1999;22:757-65.
60. Mitler MM, Harsh J, Hirshkowitz M, et al. Long-term efficacy and safety of modafinil (PROVIGIL) for the treatment of excessive daytime sleepiness associated with narcolepsy. Sleep Med 2000;1: 231-43.
61. Moldofsky H, Broughton RJ, Hill JD. A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy. Sleep Med 2000;1:109-16.
62. Jasinski DR, Kovacevic-Ristanovic R. Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy. Clin Neuropharmacol 2000; 23:149-56.
63. Jasinski DR. An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J Psychopharmacol 2000;14: 53-60.
64. Arnulf I, Homeyer P, Garma L, et al. Modafinil in obstructive sleep apnea-hypopnea syndrome: a pilot study in 6 patients. Respiration 1997;64:159-61.
65. Heitmann J, Cassel W, Grote L, et al. Does short-term treatment with modafinil affect blood pressure in patients with obstructive sleep apnea? Clin Pharmacol Ther 1999;65:328-35.
66. Kingshott R, Vennelle M, Coleman EL, et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 2001;163:918-23.
67. Schiza S, Fraggedaki A, Basta M, et al. The use of modafinil in patients with obstructive apnea hypopnea syndrome. A randomized, placebo-controlled, double-blind study [abstract]. Sleep 2001;24: A10-A11.
68. Pack AI, Black JE, Schwartz JR, et al. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med 2001;164:1675-81.
69. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
70. Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal nCPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993;147:887-95.
71. Dinges DF, Powell JW. Microcomputer analyses of performance on a portable, simple visual RT task during sustained operations. Behav Res Methods Instrum Comput 1985;17:652-5.
72. Kribbs NB, Dinges DF. Vigilance decrement and sleepiness. In: Harsh JR, Ogilvie RD, editors. Sleep onset mechanisms. Washington, DC: American Psychological Association; 1994. p. 113-25.
73. Dinges DF, Maislin G, Staley B, et al. Sleepiness and neurobehavioral functioning in relation to apnea severity in a cohort of commercial motor vehicle operators [abstract]. Sleep 1998;21:83.
74. Dinges DF, Douglas SD, Zaugg L, et al. Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation. J Clin Invest 1994;93:1930-9.
75. Dinges DF, Pack F, Williams K, et al. Cumulative sleepiness, mood disturbance, and psychomotor vigilance performance decrements during a week of sleep restricted to 4-5 hours per night. Sleep 1997; 20:267-77.
76. Hughes RJ, Van Dongen H, Dinges DF, et al. Modafinil improves alertness and performance during simulated night work [abstract]. Sleep 2001;24:A200.
77. Carskadon MA, Dement WC, Mitler MM, et al. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986;9:519-24.
78. Guy W. ECDEU Assessment manual for psychopharmacology. Washington, DC: National Institute of Mental Health, US Dept. of Health, Education, and Welfare, 1976
79. Johns MW. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res 2000;9:5-11.
80. Briones B, Adams N, Strauss M, et al. Relationship between sleepiness and general health status. Sleep 1996;19:583-8.
81. Ferrer M, Vilagut G, Monasterio C, et al. Measurement of the perceived impact of sleep problems: the Spanish version of the functional outcomes sleep questionnaire and the Epworth sleepiness scale. Med Clin (Barc) 1999;113:250-5.
82. Doran SM, Van Dongen HP, Dinges DF. Sustained attention performance during sleep deprivation: Evidence of state instability. Arch Ital Biol: Neurosci 2001;139:253-67.
83. Chugh DK, Weaver TE, Dinges DF. Psychomotor vigilance performance in sleep apnea patients compared to patients presenting with snoring without apnea [abstract]. Sleep 1998;21:159.
84. Powell NB, Riley RW, Schechtman KB, et al. A comparative model: reaction time performance in sleep-disordered breathing versus alcohol-impaired controls. Laryngoscope 1999;109:1648-54.
85. Van Dongen HPA, Maislin G, Mullington JM, et al. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 2003;26(2):117-26.
86. Belenky G, Wesensten NJ, Thorne DR, et al. Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep-dose response study. J Sleep Res 2003;12:1-12.
87. Carskadon MA, Dement WC. Cumulative effects of sleep restriction on daytime sleepiness. Psychophysiology 1981;18:107-13.
88. Kribbs NB, Getsy J, Dinges DF. Investigation and management of daytime sleepiness in sleep apnea. In: Saunders NA, Sullivan CE, editors. Sleep and breathing, vol. 2.; 1994. p. 575-604.
89. Chugh D, Dinges DF. Mechanisms of sleepiness in obstructive sleep apnea. In: Pack AI, editor. Sleep apnea: Pathogenesis, diagnosis, and treatment. New York: Marcel Dekker, Inc; 2002. p. 265-85.
90. Weaver TE. Adherence to nCPAP treatment and functional status in adult obstructive sleep apnea. In: Pack AI, editor. Sleep apnea. Pathogenesis, diagnosis and treatment. New York: Marcel Decker Inc; 2002. p. 523-54.
91. Schmidt H, Berendts B. Narcolepsy and sleep disordered breathing: insights into sleep fragmentation and treatment failures. Sleep 1999; 22(Suppl. 1):S64-5.
92. Van Dongen HPA, Rogers NL, Dinges DF. Sleep debt: theoretical and empirical issues. Sleep Biol Rhythms 2003;1:5-13.
93. Barnes M, Houston D, Worsnop CJ, et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med 2002;165:773-80.
94. Veale D, Poussin G, Benes F, et al. Identification of quality of life concerns of patients with obstructive sleep apnoea at the time of initiation of continuous positive airway pressure: a discourse analysis. Qual Life Res 2002;11:389-99.
95. Black J. Pro: Modafinil has a role in management of sleep apnea. Am J Respir Crit Care Med 2003;167:105-108.
96. Pollak C. Con: Modafinil has no role in management of sleep apnea. Am J Respir Crit Care Med 2003;167:106-108.
97. Pack AI. Should a pharmaceutical be approved for the broad indication of excessive sleepiness? Am J Respir Crit Care Med 2003;167:109-111.